Crystec and Juniper Pharma Services are working together as part of the Advanced Manufacturing Supply Chain Initiative (AMSCI) project ReMediES (Re-configuring medicines end-to-end supply)
Crystec have recently featured in a Nesta report, published in December 2015. The article focuses on interactions and partnering with China.
Crystec are working in partnership with 22 organisations as part of the AMSCI ReMediES consortium, providing supercritical fluid (SCF) technology solutions to optimise the pharmaceutical supply chain.
'Need for particle engineering increases' - an article published on PharmTech.com today gives an interesting perspective on a number of particle engineering technologies including supercritical fluid processing.